BrilliantStrings Therapeutics, Inc.
BrilliantStrings Therapeutics specializes in the development of next-generation collagen-based therapies aimed at improving connective tissue repair and wound healing. Leveraging decades of research in extracellular matrix science and collagen assembly, the company utilizes a proprietary platform to deliver complete human collagen via a targeted, injectable system designed for rapid musculoskeletal and tendon injury treatment.
Industries
Nr. of Employees
small (1-50)
BrilliantStrings Therapeutics, Inc.
700 Main Street North Cambridge, MA 02139
BrilliantStrings Therapeutics, Inc. is currently seeking investment
BrilliantStrings Therapeutics, Inc. is seeking a seed investment in the range of 1m-5m
Products
An injectable dense collagen solution for tendon and rotator cuff injury treatment, designed to home to injury sites and support tissue repair with controlled therapeutic release.
An injectable dense collagen solution for tendon and rotator cuff injury treatment, designed to home to injury sites and support tissue repair with controlled therapeutic release.
Expertise Areas
- Connective tissue repair
- Musculoskeletal therapeutics
- Collagen-based biomaterials
- Wound healing therapies
Key Technologies
- Injectable collagen platform
- Liquid-crystal drug delivery system
- Extracellular matrix engineering
Key People
CEO & Founder
Board Chairwoman
Scientific Advisory Chair
Chief of Operations
Steven Arnoczky
Pre-clinical trials consultant
Bowman Bagley
Scientific Advisory Board Member
CEO & Founder
Board Chairwoman
Scientific Advisory Chair
Chief of Operations
Steven Arnoczky
Pre-clinical trials consultant
Bowman Bagley
Scientific Advisory Board Member